These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 18243708)

  • 21. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
    Manuelidis L
    J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of recombinant prions with compounds of therapeutical significance.
    Georgieva D; Schwark D; von Bergen M; Redecke L; Genov N; Betzel C
    Biochem Biophys Res Commun; 2006 Jun; 344(2):463-70. PubMed ID: 16630566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prion protein fate governed by metal binding.
    Tsenkova RN; Iordanova IK; Toyoda K; Brown DR
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1005-12. PubMed ID: 15541389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion agent diversity and species barrier.
    Béringue V; Vilotte JL; Laude H
    Vet Res; 2008; 39(4):47. PubMed ID: 18519020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational conversion of prion protein in prion diseases.
    Zhou Z; Xiao G
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of prion protein binding proteins by combined use of far-Western immunoblotting, two dimensional gel electrophoresis and mass spectrometry.
    Strom A; Diecke S; Hunsmann G; Stuke AW
    Proteomics; 2006 Jan; 6(1):26-34. PubMed ID: 16294306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Ferrari S; Benedetti D; Sbriccoli M; Rizzuto N; Monaco S
    Ann N Y Acad Sci; 2009 Jul; 1170():637-43. PubMed ID: 19686205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
    Caughey B; Caughey WS; Kocisko DA; Lee KS; Silveira JR; Morrey JD
    Acc Chem Res; 2006 Sep; 39(9):646-53. PubMed ID: 16981681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible role for Ca2+ in the pathophysiology of the prion protein?
    Peggion C; Bertoli A; Sorgato MC
    Biofactors; 2011; 37(3):241-9. PubMed ID: 21698700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of the cellular prion protein with raft-like lipid membranes.
    Elfrink K; Nagel-Steger L; Riesner D
    Biol Chem; 2007 Jan; 388(1):79-89. PubMed ID: 17214553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The binding of the molecular chaperone Hsc70 to the prion protein PrP is modulated by pH and copper.
    Wilkins S; Choglay AA; Chapple JP; van der Spuy J; Rhie A; Birkett CR; Cheetham ME
    Int J Biochem Cell Biol; 2010 Jul; 42(7):1226-32. PubMed ID: 20434583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of the human prion protein reveals a mechanism for oligomerization.
    Knaus KJ; Morillas M; Swietnicki W; Malone M; Surewicz WK; Yee VC
    Nat Struct Biol; 2001 Sep; 8(9):770-4. PubMed ID: 11524679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prion protein oligomer and its neurotoxicity.
    Huang P; Lian F; Wen Y; Guo C; Lin D
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion protein: structural features and related toxicity.
    Hu PP; Huang CZ
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):435-41. PubMed ID: 23615535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prion proteins from susceptible and resistant sheep exhibit some distinct cell biological features.
    Sabuncu E; Paquet S; Chapuis J; Moudjou M; Lai TL; Grassi J; Baron U; Laude H; Vilette D
    Biochem Biophys Res Commun; 2005 Nov; 337(3):791-8. PubMed ID: 16214113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prions at the crossroads: the need to identify the active TSE agent.
    Nandi PK
    Bioessays; 2004 May; 26(5):469-73. PubMed ID: 15112226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.